Tiagabine-induced nonconvulsive status epilepticus in an adolescent without epilepsy.
Jette
Nathalie
N
Comprehensive Epilepsy Center, Neurological Institute of New York, 710 W. 168 St., New York, NY 10032, USA.
Cappell
Joshua
J
VanPassel
Leonie
L
Akman
Cigdem Inan
CI
D000293:Adolescent; D062787:Drug Overdose; D004569:Electroencephalography; D005260:Female; D018757:GABA Modulators / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D007262:Infusions, Intravenous; D008874:Midazolam / Q000008:administration & dosage / Q000627:therapeutic use; D008991:Monitoring, Physiologic / Q000379:methods; D014179:Neurotransmitter Uptake Inhibitors / Q000009:adverse effects*; D009557:Nipecotic Acids / Q000009:adverse effects*; D013226:Status Epilepticus / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology; D013690:Television; D000078308:Tiagabine; D016896:Treatment Outcome
D018757:GABA Modulators; D014179:Neurotransmitter Uptake Inhibitors; D009557:Nipecotic Acids; D008874:Midazolam; D000078308:Tiagabine